Yue-feng Du
Xi'an, 710061, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
BUB1B Promotes Proliferation of Prostate Cancer via Transcriptional Regulation of MELK.
Journal: Anti-cancer agents in medicinal chemistry
Published: June 24, 2019
FOXM1-Dependent Transcriptional Regulation of EZH2 Induces Proliferation and Progression in Prostate Cancer.
Journal: Anti-cancer agents in medicinal chemistry
Published: June 24, 2019
A common genetic variation in CEBPE and acute lymphoblastic leukemia: a meta-analysis of the available evidence.
Journal: OncoTargets and therapy
Published: September 22, 2015
miR-124 represses FZD5 to attenuate P-glycoprotein-mediated chemo-resistance in renal cell carcinoma.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: January 23, 2015
Downregulation of mTOR by lentivirus inhibits prostate cancer cell growth.
Journal: International journal of clinical and experimental pathology
Published: December 31, 2013
Interaction of CCN1 with αvβ3 integrin induces P-glycoprotein and confers vinblastine resistance in renal cell carcinoma cells.
Journal: Anti-cancer drugs
Published: June 08, 2013
Prostate-targeted mTOR-shRNA inhibit prostate cancer cell growth in human tumor xenografts.
Journal: International journal of clinical and experimental medicine
Published: October 16, 2012
Replication and fine mapping for association of the C2orf43, FOXP4, GPRC6A and RFX6 genes with prostate cancer in the Chinese population.
Journal: PloS one
Published: January 04, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026